BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.2 Billion USD | 32.52% |
| 2022 | -1.78 Billion USD | -24.39% |
| 2021 | -1.43 Billion USD | 13.21% |
| 2020 | -1.65 Billion USD | -72.69% |
| 2019 | -959.89 Million USD | -36.01% |
| 2018 | -705.76 Million USD | -616.83% |
| 2017 | -98.45 Million USD | 15.89% |
| 2016 | -117.06 Million USD | -106.29% |
| 2015 | -56.74 Million USD | -260.13% |
| 2014 | -15.75 Million USD | -188.7% |
| 2013 | -5.45 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -261.34 Million USD | 31.9% |
| 2024 Q2 | -107.16 Million USD | 59.0% |
| 2023 Q3 | -133.96 Million USD | 57.97% |
| 2023 Q4 | -383.79 Million USD | -186.48% |
| 2023 FY | -1.2 Billion USD | 32.52% |
| 2023 Q1 | -371.25 Million USD | 20.78% |
| 2023 Q2 | -318.71 Million USD | 14.15% |
| 2022 FY | -1.78 Billion USD | -24.39% |
| 2022 Q2 | -439.39 Million USD | 0.88% |
| 2022 Q1 | -443.28 Million USD | 24.46% |
| 2022 Q4 | -468.62 Million USD | -6.9% |
| 2022 Q3 | -438.35 Million USD | 0.24% |
| 2021 Q3 | -462.32 Million USD | 2.64% |
| 2021 Q4 | -586.8 Million USD | -26.92% |
| 2021 FY | -1.43 Billion USD | 13.21% |
| 2021 Q1 | 70.16 Million USD | 114.47% |
| 2021 Q2 | -474.83 Million USD | -776.73% |
| 2020 Q3 | -440.13 Million USD | -22.64% |
| 2020 Q4 | -484.91 Million USD | -10.17% |
| 2020 FY | -1.65 Billion USD | -72.69% |
| 2020 Q2 | -358.87 Million USD | 3.98% |
| 2020 Q1 | -373.75 Million USD | 3.68% |
| 2019 FY | -959.89 Million USD | -36.01% |
| 2019 Q4 | -388.03 Million USD | -24.26% |
| 2019 Q1 | -173.75 Million USD | 38.12% |
| 2019 Q2 | -85.83 Million USD | 50.6% |
| 2019 Q3 | -312.26 Million USD | -263.81% |
| 2018 Q2 | -163.05 Million USD | -47.15% |
| 2018 Q1 | -110.8 Million USD | -6.75% |
| 2018 FY | -705.76 Million USD | -616.83% |
| 2018 Q4 | -280.8 Million USD | -85.84% |
| 2018 Q3 | -151.1 Million USD | 7.33% |
| 2017 FY | -98.45 Million USD | 15.89% |
| 2017 Q2 | -58.02 Million USD | -12.57% |
| 2017 Q3 | 114.9 Million USD | 298.04% |
| 2017 Q4 | -103.79 Million USD | -190.33% |
| 2017 Q1 | -51.54 Million USD | -38.29% |
| 2016 Q1 | -20.33 Million USD | 22.91% |
| 2016 Q4 | -37.27 Million USD | -7.01% |
| 2016 Q3 | -34.82 Million USD | -41.42% |
| 2016 Q2 | -24.62 Million USD | -21.12% |
| 2016 FY | -117.06 Million USD | -106.29% |
| 2015 FY | -56.74 Million USD | -260.13% |
| 2015 Q2 | -6.56 Million USD | 33.09% |
| 2015 Q1 | -9.81 Million USD | -52.05% |
| 2015 Q3 | -13.99 Million USD | -113.13% |
| 2015 Q4 | -26.37 Million USD | -88.51% |
| 2014 Q3 | -5.72 Million USD | -219.2% |
| 2014 Q4 | -6.45 Million USD | -12.81% |
| 2014 FY | -15.75 Million USD | -188.7% |
| 2014 Q1 | -1.79 Million USD | 0.0% |
| 2014 Q2 | -1.79 Million USD | 0.0% |
| 2013 FY | -5.45 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -2510.982% |
| Jaguar Health, Inc. | -34.29 Million USD | -3422.02% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -610.68% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -2027.832% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -328.01% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 10213.348% |
| ContextLogic Inc. | -328 Million USD | -268.212% |
| MiMedx Group, Inc. | 37.11 Million USD | 3353.95% |
| MEI Pharma, Inc. | 14.54 Million USD | 8405.157% |
| AlloVir, Inc. | -181.33 Million USD | -566.039% |
| Novavax, Inc. | -566.51 Million USD | -113.188% |
| Aptorum Group Limited | -10.52 Million USD | -11376.747% |
| Ardelyx, Inc. | -63.27 Million USD | -1808.679% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -489.134% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -43788.547% |
| Vaxcyte, Inc. | -468.04 Million USD | -158.041% |
| Precigen, Inc. | -88.92 Million USD | -1258.182% |
| Pharming Group N.V. | -4.87 Million USD | -24651.001% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -621.847% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -3958.798% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -5793.983% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -412.626% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -6119.507% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -4868.756% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -4868.756% |
| Bicycle Therapeutics plc | -189.94 Million USD | -535.831% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -340.772% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -4021.263% |
| Acelyrin, Inc. | -422.06 Million USD | -186.15% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -3089.247% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -3158.515% |
| Senti Biosciences, Inc. | -92.72 Million USD | -1202.464% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -952.282% |
| AbCellera Biologics Inc. | -237.2 Million USD | -409.149% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -3424.487% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -603.063% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -38095.319% |
| Chimerix, Inc. | -93.06 Million USD | -1197.734% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -3557.479% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -6786.003% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -2579.255% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -2282.451% |
| Elevation Oncology, Inc. | -45.44 Million USD | -2557.577% |
| Alkermes plc | 414.12 Million USD | 391.638% |
| Fortress Biotech, Inc. | -142.34 Million USD | -748.475% |
| Fortress Biotech, Inc. | -142.34 Million USD | -748.475% |
| Agenus Inc. | -159.54 Million USD | -656.969% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -1136.244% |
| Dyadic International, Inc. | -8.22 Million USD | -14575.265% |
| ImmuCell Corporation | -5.74 Million USD | -20911.128% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -101220.134% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -798.419% |
| Lantern Pharma Inc. | -17.87 Million USD | -6655.594% |
| Immix Biopharma, Inc. | -16.14 Million USD | -7382.359% |
| Incyte Corporation | 620.52 Million USD | 294.631% |
| IO Biotech, Inc. | -91.44 Million USD | -1220.753% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -1554.909% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -5911.69% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -2173.326% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -836.317% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -14106.987% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -1339.254% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -217.411% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -139.48% |
| NextCure, Inc. | -67.63 Million USD | -1685.614% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -11333.646% |
| Onconetix, Inc. | -36.03 Million USD | -3251.601% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -2795.277% |
| Opthea Limited | -191.84 Million USD | -529.545% |
| PDS Biotechnology Corporation | -43.04 Million USD | -2705.737% |
| PureTech Health plc | -146.19 Million USD | -726.09% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -1369.337% |
| Seer, Inc. | -103.46 Million USD | -1067.312% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -9365868.357% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -4761.278% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -30537.273% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -4027.883% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -1676.187% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -2644.231% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -768.681% |
| ChromaDex Corporation | -5.59 Million USD | -21470.566% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -17408.495% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -940.622% |
| CRISPR Therapeutics AG | -222.53 Million USD | -442.71% |
| Precision BioSciences, Inc. | -43.73 Million USD | -2661.423% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -533.946% |
| Innoviva, Inc. | 176.7 Million USD | 783.46% |
| Summit Therapeutics Inc. | -89.73 Million USD | -1245.877% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -1736.609% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -1578.973% |
| ESSA Pharma Inc. | -32.13 Million USD | -3658.424% |
| GlycoMimetics, Inc. | -39.27 Million USD | -2975.053% |
| GT Biopharma, Inc. | -13.57 Million USD | -8796.111% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -450.922% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 1491.209% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -2244.845% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -12053.141% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -365.124% |
| Aptose Biosciences Inc. | -52.35 Million USD | -2206.777% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -8274.973% |
| Soligenix, Inc. | -7.69 Million USD | -15589.08% |
| Century Therapeutics, Inc. | -146.54 Million USD | -724.134% |
| Kura Oncology, Inc. | -165.8 Million USD | -628.412% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -1192.277% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -14417.803% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -48566.869% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -18526.403% |
| Autolus Therapeutics plc | -195.02 Million USD | -519.263% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -1326.623% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -1539.564% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -5614.388% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -431.96% |
| GRI Bio, Inc. | -11.38 Million USD | -10506.27% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -26645.178% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -820.58% |
| IGM Biosciences, Inc. | -263.46 Million USD | -358.412% |
| INmune Bio, Inc. | -29.74 Million USD | -3960.845% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -991.837% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -3071.965% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -7458.099% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -7558.038% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -1876.719% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -1023.245% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -337.576% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -494.361% |
| Verastem, Inc. | -92.08 Million USD | -1211.559% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -2462.291% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -555.861% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -920.22% |
| Histogen Inc. | -10.64 Million USD | -11247.703% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -7705.966% |
| Surrozen, Inc. | -45.78 Million USD | -2538.13% |
| Organovo Holdings, Inc. | -15.08 Million USD | -7905.674% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -23626.523% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -1937.291% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -2254.537% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -4677.437% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -15722.885% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -605.111% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -2392.852% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -1444.321% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -7834.787% |
| Apollomics, Inc. | -54.83 Million USD | -2102.531% |
| Amarin Corporation plc | -67.58 Million USD | -1686.909% |
| Mesoblast Limited | -58.79 Million USD | -1954.182% |
| Turnstone Biologics Corp. | -59.03 Million USD | -1945.901% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -629.618% |
| Synaptogenix, Inc. | -8.31 Million USD | -14426.789% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -8180.104% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -1217.181% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -25105.981% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -13575.732% |
| Exelixis, Inc. | 170.88 Million USD | 806.754% |
| Better Therapeutics, Inc. | -38.26 Million USD | -3056.489% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -678.868% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -133.55% |
| NLS Pharmaceutics AG | -11.8 Million USD | -10128.928% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -14918.032% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -3926.726% |
| Gritstone bio, Inc. | -154.63 Million USD | -681.029% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -1653.875% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -6953.275% |
| Avid Bioservices, Inc. | -18.67 Million USD | -6366.088% |
| Insmed Incorporated | -709.62 Million USD | -70.193% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -7597.593% |
| MediWound Ltd. | -15.29 Million USD | -7798.862% |
| OmniAb, Inc. | -69.41 Million USD | -1639.777% |
| Alector, Inc. | -151.74 Million USD | -695.925% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -1018.45% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -2215.978% |
| Zai Lab Limited | -366.57 Million USD | -229.467% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -281.257% |
| Aura Biosciences, Inc. | -84.99 Million USD | -1321.016% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -391.951% |
| Immunic, Inc. | -99.22 Million USD | -1117.194% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -743.638% |
| Veracyte, Inc. | -85.79 Million USD | -1307.7% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -328.556% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -8399.198% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -17434.049% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -6326.651% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 308.741% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -4644.965% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 3212.561% |
| TG Therapeutics, Inc. | 20.63 Million USD | 5953.419% |
| Galecto, Inc. | -39.9 Million USD | -2926.528% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -2770.504% |
| Fortrea Holdings Inc. | 63.1 Million USD | 2014.003% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -759.935% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -4082.201% |
| XBiotech Inc. | -37.51 Million USD | -3119.771% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -1653.875% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -1699.368% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -1019.248% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -4604.487% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -2166.261% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -112.178% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -1438.674% |
| Vaxxinity, Inc. | -58.28 Million USD | -1972.121% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -1064.543% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -5327.263% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -1297.584% |
| NexImmune, Inc. | -29.19 Million USD | -4037.148% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -21389.46% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -8182.729% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 129.842% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -4643.847% |
| Scopus BioPharma Inc. | -11.71 Million USD | -10209.421% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -850.509% |
| Ainos, Inc. | -13.2 Million USD | -9045.084% |
| Pluri Inc. | -22.15 Million USD | -5350.564% |
| Prothena Corporation plc | -191.03 Million USD | -532.203% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -774.93% |
| Celularity Inc. | -192.28 Million USD | -528.09% |
| Rallybio Corporation | -78.93 Million USD | -1430.097% |
| Cue Biopharma, Inc. | -52.14 Million USD | -2215.933% |
| MeiraGTx Holdings plc | -137.06 Million USD | -781.167% |
| Omeros Corporation | -164.53 Million USD | -634.052% |
| Humacyte, Inc. | -100.04 Million USD | -1107.169% |
| Immunocore Holdings plc | -59.64 Million USD | -1924.738% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -6407.549% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -4832.958% |
| Blueprint Medicines Corporation | -486.27 Million USD | -148.364% |
| CalciMedica, Inc. | -21.87 Million USD | -5421.079% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -1517.648% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -818.535% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -605.062% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -269.451% |
| Pulmatrix, Inc. | -14.74 Million USD | -8093.596% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -3278.755% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -1259.053% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -134.379% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -1687.888% |
| Cytokinetics, Incorporated | -496.2 Million USD | -143.395% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -3408.922% |
| Nutriband Inc. | -4.87 Million USD | -24689.703% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -2669.211% |
| Vor Biopharma Inc. | -126.03 Million USD | -858.247% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 128.471% |
| Evogene Ltd. | -26.39 Million USD | -4476.318% |
| ProKidney Corp. | -151.52 Million USD | -697.07% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -1771.443% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -15600.702% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | -98.847% |
| CorMedix Inc. | -48.95 Million USD | -2366.892% |
| BioLineRx Ltd. | -49.69 Million USD | -2330.346% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -957.812% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -3072.242% |
| Atai Life Sciences N.V. | -125.47 Million USD | -862.562% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -1379.356% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -1383.541% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -385.058% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -3828.874% |
| MediciNova, Inc. | -9.9 Million USD | -12099.027% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -855.691% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -16575.773% |
| GeoVax Labs, Inc. | -26.74 Million USD | -4416.093% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -420.969% |
| Biomea Fusion, Inc. | -126.13 Million USD | -857.495% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -245.658% |
| Mereo BioPharma Group plc | -28.41 Million USD | -4150.197% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -532.028% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -425.208% |
| Absci Corporation | -115.51 Million USD | -945.523% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -4277.917% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -970.052% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -398.731% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -4693.364% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -480.659% |
| Allakos Inc. | -196.05 Million USD | -516.016% |
| Imunon, Inc. | -21.03 Million USD | -5642.802% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -991.354% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 1225.758% |
| BioAtla, Inc. | -129.68 Million USD | -831.27% |
| NLS Pharmaceutics AG | -11.8 Million USD | -10128.928% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -7523.152% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -268.508% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -2792.227% |
| XOMA Corporation | -41.84 Million USD | -2786.006% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -1047.634% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -894.062% |
| aTyr Pharma, Inc. | -54.91 Million USD | -2099.122% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -1281.422% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -598.638% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -374.646% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -5526.274% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -14605.613% |
| Akari Therapeutics, Plc | -16.8 Million USD | -7086.338% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -13657390.702% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 457.769% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -18383.807% |
| UroGen Pharma Ltd. | -65.53 Million USD | -1742.859% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -1252.781% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -16528.583% |
| Orgenesis Inc. | -53.63 Million USD | -2151.726% |
| Entera Bio Ltd. | -8.89 Million USD | -13483.804% |
| GH Research PLC | -41.22 Million USD | -2829.834% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -4597.899% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -1354.175% |
| Xencor, Inc. | -138.63 Million USD | -771.137% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -23330.334% |
| Replimune Group, Inc. | -234.77 Million USD | -414.427% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -5519.698% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -8556.365% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -18383.807% |
| Portage Biotech Inc. | -18.25 Million USD | -6516.644% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -16575.773% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -1050.652% |
| OncoCyte Corporation | -25.13 Million USD | -4704.806% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -10583.337% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -10441.412% |
| Purple Biotech Ltd. | 22.27 Million USD | 5522.909% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -15977.423% |
| scPharmaceuticals Inc. | -55.39 Million USD | -2080.186% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -6290.918% |
| HilleVax, Inc. | -133.34 Million USD | -805.723% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -9923.537% |
| Tharimmune, Inc. | -9.45 Million USD | -12673.219% |
| Genprex, Inc. | -31.07 Million USD | -3786.448% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -541.751% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -3749.112% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -157773.987% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -22072.828% |
| OKYO Pharma Limited | -15.74 Thousand USD | -7668196.536% |
| Savara Inc. | -60 Million USD | -1912.659% |
| Curis, Inc. | -48.33 Million USD | -2398.833% |
| Daré Bioscience, Inc. | -30.83 Million USD | -3816.15% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -23048.767% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -16496.619% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -4332.059% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -5957.063% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -147.901% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -1189.6% |
| Erasca, Inc. | -141.52 Million USD | -753.373% |
| bluebird bio, Inc. | -244.26 Million USD | -394.443% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -26578.66% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 721.132% |
| DBV Technologies S.A. | -76.43 Million USD | -1480.144% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -26578.66% |
| Moderna, Inc. | -4.23 Billion USD | 71.509% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -2734.462% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -18889.56% |
| Molecular Templates, Inc. | -10.46 Million USD | -11439.614% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -1696.237% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -220.572% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -742.738% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -2222.882% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -681.494% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -480.28% |
| MacroGenics, Inc. | -168.24 Million USD | -617.848% |
| RenovoRx, Inc. | -11.39 Million USD | -10497.894% |
| Adicet Bio, Inc. | -152.03 Million USD | -694.365% |
| Prime Medicine, Inc. | -191.29 Million USD | -531.357% |
| Aditxt, Inc. | -26.06 Million USD | -4534.012% |
| Adagene Inc. | -23.71 Million USD | -4991.665% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -16421.475% |
| Quantum-Si incorporated | -111.17 Million USD | -986.377% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -3716.153% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -8184.78% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 1089.834% |
| SciSparc Ltd. | -5.77 Million USD | -20820.423% |
| Vericel Corporation | -6.46 Million USD | -18584.035% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -13851.518% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -5123.867% |
| Generation Bio Co. | -138.56 Million USD | -771.615% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -1354.578% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -1296.873% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -400.925% |
| Invivyd, Inc. | -207.78 Million USD | -481.249% |
| Relay Therapeutics, Inc. | -373 Million USD | -223.79% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -12777.704% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 5722.345% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -11640.41% |
| 2seventy bio, Inc. | -216.7 Million USD | -457.323% |
| ADMA Biologics, Inc. | 21.63 Million USD | 5683.099% |
| Clene Inc. | -40.54 Million USD | -2879.122% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -4915.961% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -2104.059% |
| GeoVax Labs, Inc. | -26.74 Million USD | -4416.093% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -245.008% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -3187.965% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 7612.198% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -1064.622% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -3451.956% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -609.273% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -76.491% |
| Evaxion Biotech A/S | -22.19 Million USD | -5340.988% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -1366.019% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -441.285% |
| Trevena, Inc. | -35.28 Million USD | -3322.512% |
| Surrozen, Inc. | -45.78 Million USD | -2538.13% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -1410.709% |
| Cingulate Inc. | -22.75 Million USD | -5206.586% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 16220.342% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -2603.866% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -14567.776% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -1077.613% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -1545.888% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -1845.639% |
| Clearmind Medicine Inc. | -8.74 Million USD | -13716.355% |
| Kronos Bio, Inc. | -121.83 Million USD | -891.329% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -1485.039% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -41077.708% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -1097.83% |
| Statera Biopharma, Inc. | -98.34 Million USD | -1128.075% |
| ImmunityBio, Inc. | -362.25 Million USD | -233.398% |
| Korro Bio, Inc. | -84.53 Million USD | -1328.699% |
| Kineta, Inc. | -15.72 Million USD | -7581.333% |
| BioVie Inc. | -32.17 Million USD | -3653.112% |
| Codexis, Inc. | -68.06 Million USD | -1674.282% |
| Celularity Inc. | -192.28 Million USD | -528.09% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -442.539% |
| Celcuity Inc. | -66.23 Million USD | -1723.539% |
| Virax Biolabs Group Limited | -6.49 Million USD | -18490.641% |
| Cibus, Inc. | -318.88 Million USD | -278.74% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -2708.688% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -3468.538% |
| IN8bio, Inc. | -30.33 Million USD | -3881.066% |
| Kodiak Sciences Inc. | -277.32 Million USD | -335.501% |
| Annexon, Inc. | -143.72 Million USD | -740.322% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -875.625% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -1768.23% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -5051.578% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -241.429% |
| Eyenovia, Inc. | -25.4 Million USD | -4653.66% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 3800.172% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -21614.06% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -1426.21% |
| Arcellx, Inc. | -89.88 Million USD | -1243.721% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -2559.508% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -780.229% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -3782.272% |
| Moolec Science SA | -6.65 Million USD | -18051.058% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -1875.426% |
| Geron Corporation | -193.94 Million USD | -522.724% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -2692.259% |
| Royalty Pharma plc | 1.49 Billion USD | 180.939% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -635.698% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -12847.613% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -5416.121% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -606.456% |
| Humacyte, Inc. | -100.04 Million USD | -1107.169% |
| Structure Therapeutics Inc. | -102.77 Million USD | -1075.126% |
| 89bio, Inc. | -151.2 Million USD | -698.746% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -1407.183% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -8206.3% |
| Genelux Corporation | -24.16 Million USD | -4897.873% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -3460.228% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -603.194% |
| Notable Labs, Ltd. | -14.65 Million USD | -8139.995% |
| Liquidia Corporation | -73.38 Million USD | -1545.776% |
| Mustang Bio, Inc. | -50.72 Million USD | -2280.901% |
| Immunovant, Inc. | -282.7 Million USD | -327.201% |
| Quantum-Si incorporated | -111.17 Million USD | -986.377% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -1446.338% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -5578.92% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -1083.916% |
| Acasti Pharma Inc. | -11.31 Million USD | -10576.591% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -5169.1% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -7458.099% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -464.22% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -32816.661% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -7502.518% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -4042.182% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -2818.365% |
| PepGen Inc. | -84.76 Million USD | -1324.788% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -3975.92% |
| United Therapeutics Corporation | 1.18 Billion USD | 201.927% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -5174.647% |
| Solid Biosciences Inc. | -104.31 Million USD | -1057.778% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -3581.211% |
| Immuneering Corporation | -58.41 Million USD | -1967.585% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -23626.523% |
| Silo Pharma, Inc. | -3.85 Million USD | -31224.269% |
| Belite Bio, Inc | -31.66 Million USD | -3713.743% |
| XOMA Corporation | -41.84 Million USD | -2786.006% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -1688.709% |
| Bionomics Limited | -17.89 Billion USD | 93.25% |
| Apogee Therapeutics, Inc. | -93 Million USD | -1198.599% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 3484.91% |
| uniQure N.V. | -282.87 Million USD | -326.956% |
| Cassava Sciences, Inc. | -105.95 Million USD | -1039.836% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -16421.475% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -832.586% |
| Forte Biosciences, Inc. | -32.48 Million USD | -3617.712% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -14435.704% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -4008.644% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -21614.06% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -8399.198% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -13486.86% |
| Altimmune, Inc. | -95.92 Million USD | -1158.989% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -1543.312% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 3484.91% |
| Compugen Ltd. | -12.99 Million USD | -9195.998% |
| Peak Bio, Inc. | -1356.23 USD | -89050872.18% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -2334.755% |
| Benitec Biopharma Inc. | -22.49 Million USD | -5270.102% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -398.44% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -3960.163% |
| Zura Bio Limited | -62.63 Million USD | -1828.12% |
| PolyPid Ltd. | -22.86 Million USD | -5181.567% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -7320.349% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -3960.163% |
| Instil Bio, Inc. | -159.16 Million USD | -658.776% |
| argenx SE | -425.04 Million USD | -184.14% |
| Immunome, Inc. | -109.53 Million USD | -1002.653% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -2298.062% |
| Verona Pharma plc | -67.83 Million USD | -1680.51% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -4534.444% |
| Shattuck Labs, Inc. | -91.95 Million USD | -1213.37% |
| CervoMed Inc. | -7.81 Million USD | -15358.239% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -1551.944% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -8966.406% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -2407.029% |
| Moolec Science SA | -6.65 Million USD | -18051.058% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -7242.556% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -793.12% |
| AnaptysBio, Inc. | -164.41 Million USD | -634.583% |
| Design Therapeutics, Inc. | -78.19 Million USD | -1444.617% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -1287.548% |
| NeurAxis, Inc. | -6.66 Million USD | -18021.943% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -2882.138% |
| Lumos Pharma, Inc. | -36.61 Million USD | -3198.563% |
| Achilles Therapeutics plc | -75.25 Million USD | -1504.858% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -4534.444% |
| 180 Life Sciences Corp. | -13.47 Million USD | -8861.128% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 23522.482% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -41077.708% |
| Nutriband Inc. | -4.87 Million USD | -24689.703% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -990.211% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -2078.102% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -2275.749% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -1727.162% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -2131.461% |
| Palisade Bio, Inc. | -13.07 Million USD | -9140.52% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -2559.684% |
| Beam Therapeutics Inc. | -176.48 Million USD | -584.328% |
| Neurogene Inc. | -55.58 Million USD | -2072.851% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -1006.451% |
| AEON Biopharma, Inc. | -48.42 Million USD | -2393.828% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -1148.822% |
| Sesen Bio, Inc. | -25.9 Million USD | -4561.454% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -1345.888% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -9495.185% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -162.233% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -1567.246% |
| Athira Pharma, Inc. | -125.46 Million USD | -862.6% |
| Vaccinex, Inc. | -22.88 Million USD | -5177.413% |
| HCW Biologics Inc. | -25.71 Million USD | -4596.226% |
| XOMA Corporation | -41.84 Million USD | -2786.006% |
| Nektar Therapeutics | -137.42 Million USD | -778.833% |
| Arvinas, Inc. | -401.5 Million USD | -200.806% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -13657390.702% |
| Merus N.V. | -156.54 Million USD | -671.485% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -1104.592% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -3388.55% |
| Rezolute, Inc. | -70.42 Million USD | -1614.974% |
| Clene Inc. | -40.54 Million USD | -2879.122% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -7273.923% |
| BeyondSpring Inc. | -23.11 Million USD | -5125.128% |
| Synlogic, Inc. | -55.16 Million USD | -2089.474% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -6636.215% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -11057.945% |
| Peak Bio, Inc. | -1356.23 USD | -89050872.18% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -2881.843% |
| Krystal Biotech, Inc. | -109.72 Million USD | -1000.673% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -832.327% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -252.096% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -25347.702% |
| MannKind Corporation | 8.67 Million USD | 14017.216% |
| Ikena Oncology, Inc. | -75.41 Million USD | -1501.411% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -12419.291% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -1696.424% |
| Gossamer Bio, Inc. | -183.75 Million USD | -557.239% |
| CohBar, Inc. | -12.38 Million USD | -9649.007% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -2280.995% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -4277.917% |
| Legend Biotech Corporation | -439.48 Million USD | -174.807% |
| Mural Oncology plc | -194.63 Million USD | -520.504% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -1698.752% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -7380.432% |
| Disc Medicine, Inc. | -91.12 Million USD | -1225.362% |
| Champions Oncology, Inc. | -7.35 Million USD | -16318.38% |
| REGENXBIO Inc. | -268.12 Million USD | -350.433% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -11168.1% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -2066.109% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -2999.887% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -956.11% |
| Vaxart, Inc. | -83.34 Million USD | -1349.046% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -14075.292% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -2722.203% |
| Cellectis S.A. | -106.62 Million USD | -1032.684% |
| Longeveron Inc. | -21.02 Million USD | -5643.193% |
| Repare Therapeutics Inc. | -116.22 Million USD | -939.145% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -350.944% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -1496.584% |
| Revolution Medicines, Inc. | -487.18 Million USD | -147.901% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -18055.983% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -2647.727% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -1519.166% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -1634.381% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -10868.45% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 128.038% |
| Denali Therapeutics Inc. | -196.69 Million USD | -514.002% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -13851.518% |
| Veru Inc. | -93.78 Million USD | -1187.809% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -5076.973% |
| Cingulate Inc. | -22.75 Million USD | -5206.586% |
| Passage Bio, Inc. | -108.38 Million USD | -1014.261% |
| Context Therapeutics Inc. | -25.07 Million USD | -4716.952% |
| Exicure, Inc. | -14.99 Million USD | -7953.721% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -486.098% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -2874.866% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -12329.184% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -555.107% |
| Nuvalent, Inc. | -149.49 Million USD | -707.893% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -14598.895% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -1261.121% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -5713.69% |
| OmniAb, Inc. | -69.41 Million USD | -1639.777% |
| Anew Medical, Inc. | -1.3 Million USD | -92742.779% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -9356.863% |
| Lipocine Inc. | -17.93 Million USD | -6635.48% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -1662.784% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -1485.954% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -3071.965% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -2955.471% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -5295.533% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -108.285% |
| Ocugen, Inc. | -65.53 Million USD | -1742.999% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -1186.66% |
| Q32 Bio Inc. | -92.1 Million USD | -1211.303% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -5533.36% |
| Alumis Inc. Common Stock | -158.17 Million USD | -663.549% |
| Equillium, Inc. | -14.52 Million USD | -8216.596% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -1835.288% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -15181.319% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -6301.956% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -2472.333% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -1013.47% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -9989.678% |
| Dominari Holdings Inc. | -21.79 Million USD | -5441.09% |
| Edesa Biotech, Inc. | -9.22 Million USD | -12995.172% |
| vTv Therapeutics Inc. | -25.5 Million USD | -4635.848% |
| Bio-Techne Corporation | 206.68 Million USD | 684.334% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -208.5% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 728.931% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -813.036% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -3045.883% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -699.291% |
| Nkarta, Inc. | -131.65 Million USD | -817.384% |
| BioCardia, Inc. | -11.64 Million USD | -10272.175% |
| Iterum Therapeutics plc | -47.46 Million USD | -2444.316% |